Yeah For Pharming! At least they have some mojo (and too bad none of it is rubbing off on hapless and pathetic GTCB).
GTCB better hope they put something out soon that is of fantastic news to get the stock up over 1.00. But due to past history of SUCKING, I doubt they will.
So who will come and buy out GTCB and then install proper management?
>Based on these results, Pharming intends to file regulatory submissions for Rhucin® in several early launch markets in the second half of 2008 and will meet with EMEA and FDA to accelerate regulatory filings in Europe and the USA.<
“Early launch markets” is an obfuscating term. Why can’t they just state which jurisdictions they are talking about? The usual “competitive reasons” justification for reticence would not seem to apply in this case.